What is known in radiochemothearpy in advanced head and neck cancer?;Radiochemotherapie bei fortgeschrittenen Kopf-Hals-Tumoren - Was ist gesichert?

Strahlentherapie und Onkologie

Volumn 172, Issue 8, 1996, Pages 409-416

  Wendt, T G ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN C;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; GERMANY; HEAD AND NECK CANCER; HUMAN; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM METASTASIS;

EID: 0029949632     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Adelstein, D. J., V. M Sharan, A. S. Earle, A. C. Shah, C. Vlastou, C. D. Hana, C. Damm, S G Carter, J. D. Hines: Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer 65 (1990), 1685-1691
2. Arcangeli, G., C Nervi, R Righini, G Creton, M. A. Mirri, A. Guerra: Combined radiation and drugs: the effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer Radiother. Oncol. 1 (1983), 101-107.
3. Bachaud, J. M., N Albin, C. Gay, E. Chatelut, M. Benchalal, J. M. David, A. Boneu, E. Serrano, P. Canal, N Daly-Schveitzer: Concomitant radiochemotherapy (CDDP 4-6 mg/m(2)/d) in locally advanced head and neck cancer Bull. Cancer 81 (1994), 212-218.
4. Bachaud, J. M., J. M. David, F Boussin, N Daly: Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck preliminary report of a randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 20 (1991), 243-246.
5. Bogaert, W. van den, F Ostyn, E. van der Schueren: Hypopharyngeal cancer results of treatment with radiotherapy alone and combinations of surgery and radiotherapy. Radiother Oncol. 3 (1985), 311-318.
6. Byfield, J. E., P Calabro-Jones, I. Klisak, F Kulhanian: Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X-rays. Int. J. Radiat. Oncol. Biol Phys. 8 (1982), 1923-1933.
7. Clavel, M., G Cognetti, P. Dodion, J. Wildiers, R. Rosso, A. Rossi, B. Gignoux, M. van Rymenant, H. Cortes-Funes, O. Dalesio, A. Kirkpatrick, M. Rozencweig: Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck. Cancer 60 (1987), 1173-1177.
8. Coughlin, C T., R. C. Richmond Platinum based combined modality approach for locally advanced head and neck carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 11 (1985), 915-919.
9. Crissman, J. D., T F. Pajak, R. J. Zarbo, V A. Marcial, M. Al-Sarraf: Improved response and survival to combined cisplatin and radiation in non-keratinizing squamous cell carcinomas of the head and neck. Cancer 59 (1987), 1391-1397
10. Depondt, J., P. Gehanno, M. Martin, G. Lelievre, B. Guerrier, C Peytral, H. Schott, B. Pellae-Cosset. Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer. Oncology 50. Suppl. 2 (1993), 23-27.
11. Dobrowsky, W., E. Dobrowsky, E. M. Rausch, H Strassl, O. Braun: Praoperative Radiochemotherapie bei fortgeschrittenen Mundhohlenund Oropharynxkarzinomen. Strahlenther. Onkol. 163 (1987), 357-360.
12. Dubray, B. M., J. P. Bataini, J. Bernier, H. D. Thames, C. Lave, B. Asselain, C Jaulerry, F. Brunin, D. Pontvert: Is reseeding from the primary a plausible cause of node failure? Int. J Radiat. Oncol. Biol. Phys. 25 (1993), 9-15.
13. Ervin, T. J., J. R. Clark, R R. Weichselbaum, B. G. Fallon, D. Miller, R. L. Fabian, M. R. Posner, C. M. Norris, S. A. Tuttle, D. A. Schoenfeld, K. N , Price, E Frei: An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous cell carcinoma of the head and neck. J. clin. Oncol. 5 (1987), 10-20.
14. Eschwege, F., H. Sancho-Garnier, J. P. Gerard, M. Madelain, A. Desaulty, A. Jortay, Y. Cachin: Ten-years results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the EORTC. Nat. Cancer Inst. Monogr. 6 (1988), 275-278.
15. Fazekas, J., C. Sommer, S. Kramer: Adjuant intravenous methotrexate or definitive radiotherapy alone for avanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx - concluding report of an RTOG randomized trial on 638 patients. Int. J Radiat. Oncol. Biol. Phys. 6 (1980), 533-541.
16. Fietkau, R., H. Iro, G. G. Grabenbauer, A. Altendorf-Hofmann, R. Sauer: Simultane Radio-/Chemotherapie mit Cisplatin und 5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Tumoren. Strahlenther. Onkol 167 (1991), 693-700.
17. Fu, K. K., T. L. Phillips, I. J. Silverberg, C. Jacobs, D. R. Goffinet, C. Chun, M. A. Friedman, M. Kohler, K. McWhirter, S. K. Carter: Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group Randomized Trial. J. clin. Oncol. 5 (1987), 1410-1418.
18. Glanzmann, C.: Ergebnisse der Radiotherapie des Zungengrund-/Vallekulakarzinoms bei 171 Patienten aus dem Zeitraum 1950 bis 1976. Strahlenther. 155 (1979), 536-540.
19. Grabenbauer, G. G., H. Steininger, R. Fietkau, T. Wendt, R. Sauer: Prognostische Faktoren und Ergebnisse nach Radiotherapie (RT) vs. Radiochemotherapie (RCT) fortgeschrittener, inoperabler Plattenepithelkarzinome der Kopf-Hals-Region (SCC H&N). Strahlenther. Onkol. 171, Sondern, 1 (1995), 17.
20. Gupta, N. K., R. C S Pointon, P. M. Wilkinson: A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin. Radiol. 38 (1987), 575-581.
21. Harwood, A. R., F. A. Beale, B. J. Cummings, T. J Keane, D. G. Payne, W. D. Rider, E. Rawlinson, T. Elhakim: Supraglottic larxyngeal carcinoma: an analysis of dose-time-volume factors in 410 patients. Int. J. Radiat. Oncol. Biol. Phys. 9 (1983), 311-319.
22. Head and Neck Contracts Program: Adjuvant chemotherapy for advanced head and neck squamous carcinoma: final report of the Head and Neck Contracts Program. Cancer 60 (1987), 301-311.
23. Jacobs, C., J. R. Bertino, D. R. Goffinet: Twenty-four-hour infusion of cis-platinum in head and neck cancer. Cancer 42 (1978), 2135-2140.
24. Jacobs, C., R. Makuch: Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program. J. clin. Oncol. 8 (1990), 838-847.
25. Jaulerry, C., J. Rodriguez, F. Brunin, M. Jouve, V Mossert, D. Point, D. Pontvert, P. Validire, B. Zafrani, B. Blaszka, B. Asselain, P. Pouillart, J. Brugère: Induction chemotherapy in advanced head and neck tumors: results of two randomized trials. Int. J. Radiat. Oncol. Biol. Phys. 23 (1992), 483-489.
26. Johnson, C. R., S. R. Khandelwal, R. K. Schmidt-Ullrich, J. Ravalese III, D. E. Wazer The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. Int. J. Radiat. Oncol. Biol. Phys. 32 (1995), 635-641.
27. Keane, T. J., B. J. Cummings, B. O. Sullivan, D. Payne, E. Rawlinson, R. MacKenzie, C Danjoux, I. Hodson: A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal, squamous carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 25 (1993), 613-618
28. Kish, J. A., J. F. Ensley, J. Jacobs, A. Weaver, G. Cummings, M. Al-Sarraf. Randomised trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 56 (1985), 2740-2744.
29. Kramer, S., V. A. Marcial, T. F. Pajak, C. J. MacLean, L. W. Davis: Prognostic factors for loco-regional control and metastasis and the impact on survival. Int J. Radiat Oncol. Biol. Phys. 12 (1986), 573-578.
30. Kun, L. E., F J Toohill, P. Y. Holoye, J. A Duncavage, R. W. Byhardt, T. W. Grossman, R. G. Hoffmann, J. D. Cox, M. L Malin: A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract. Int. J. Radiat. Oncol. Biol. Phys. 12 (1986), 173-178.
31. Laramore, G. E., C. B. Scott, M. Al-Sarraf, R. E. Haselow, T. J. Ervin, R. Wheeler, J. R. Jacobs, D. E. Schuller, R. A. Gahbauer, J. G. Schwade, B. H. Campbell: Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on intergroup study 0034 Int. J. Radiat. Oncol. Biol. Phys. 23 (1992), 705-713.
32. Leemans, C. R., R. Tiwan, J J. P. Nauta, I. v d. Waal, G. B. Snow: Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 71 (1993), 452-456.
33. Leibel, S. A., C. B. Scott, M. Muhiuddin, V. A. Marcial, L. R. Coia, L W. Davis, Z. Fuks: The effect of loco-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG database Int. J Radiat. Oncol. Biol. Phys. 21 (1991), 549-556.
34. Lo, T. C. M., A. L. Wiley Jr , F. J. Ansfield, J. H. Brandenburg, H L. Davis, F F. Gollin, R O. Johnson, G. Ramirez, H. Vermund: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. Amer. J. Roentgenol. 126 (1976), 229-235
35. Löffler, T. M., F. W. Weber, T. U. Hausamen: Klinische Erfahrungen mit der ambulanten Dauerinfusion von Mitomycin. Tumordiagn. Ther. 13 (1992), 132-135.
36. Lokich, J. J., J. D. Ahlgren, J. J. Gullo, J. A. Philips J. G. Fryer: A prospective randomised comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a mid-atlantic oncology program study. J. clin. Oncol. 7 (1989), 425-432.
37. Meoz-Mendez, R. T., G H. Fletcher, O. M. Guillamondeque: Analysis of the results of irradiation in the treatment of squamous cell carcinoma of the pharyngeal walls. Int. J. Radiat. Oncol. Biol. Phys. 4 (1978), 579-585.
38. Merino, O. R., R. D Lindberg, G. H Fletcher: An analyisis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 40 (1977), 145-151.
39. Merlano, M., V. Vitale, R. Rosso, M. Benasso, R. Corvo, M. Cavallari, G. Sanguineti, A. Bacigalupo, F. Badellino, G. Margarino, F. Brema, G. Pastorino, C. Marziano, A. Grimaldi, F. Scasso, G. Sperati, E. Pallestrini, G. Garaveta, E. Accomando, G. Cordone, G. Cornella, A. Daponte, A. Rubagotti,d P. Bruzzi, L. Santi: Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. New Engl. J. Med. 327 (1992), 1115-1121.
40. Munro, A. J : An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Brit. J. Cancer 71 (1995), 83-91.
41. Nishijima, W., S. Takooda, N. Tokita, S. Takayama, M. Sakura: Analyses of distant metastases in squamous cell carcinoma of the head and neck and lesions above the clavicle at autopsy. Arch. Otolaryng. Head Neck Surg 119 (1993), 65-68
42. O'Connell, M. J., J A. Martenson, H. S. Wieand, J. E. Krook, J. S. Macdonald, D. G. Haller, R. J. Mayer, L. L Gunderson, T. A. Rich: Improving adjuvant therapy for rectal cancer by combining protracted-infusion 5-fluorouracil with radiation therapy after curative surgery. New Engl. J. Med. 331 (1994), 502-507.
43. O'Connor, A D., P. Clifford, W G. Edwards, V M. Dalley, D. J. Durden-Smith, B. A. Hollis, F. M. Calman: Long-term results of VBM and radiotherapy in advanced head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 8 (1982), 1525-1531.
44. Olver, I., P. Hughes, J. Smith, K. Narayan, J. Bishop: Late effects and survival after simultaneous continuous 5-fluorouracil (5-FU) and radiation in head and neck cancer (Meeting abstract). Proc. Annual Meeting Amer. Soc clin. Oncol. 12 (1993), A890.
45. Paccagnella, A, A. Orlando, C. Marchiori, P. L. Zorat, G. Cavaniglia, V. C Sileni, A. Jirulo, L. Tomia, G. Fila, A. Fede, L. Endrizzi, M. Bari, E. Sampognaro, M Balli, A. Gava, G. L. Pappagallo, M. V. Fiorentino: Phase III trial of initial chemotherapy in stage m and IV head and neck cancers J nat. Cancer Inst. 86 (1994), 265-272.
46. Papac, R. J : Distant metastases from head and neck cancer. Cancer 53 (1984), 342-345.
47. Parvinen, L.-M., M. Parvinen, E. Nordman, A. E. Kortekangas: Combined bleomycin treatment and radiation therapy in sqamous cell carcinoma of the head and neck region. Acta Radiol. Oncol. 24 (1985), 487-491.
48. Peters, L. J., M. L. Harrison, I. W Dimery, R. Fields, H. Goepfert, M. J. Oswald: Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx. Int. J. Radiat. Oncol. Biol. Phys. 14 (1988), 623-633.
49. Pfister, D. G , D. Bajorin, R Motzer, H. Scher, C. Louison, L. Harrison, J. Shah, E Strong, G Bosl: Cisplatin, fluorouracil, and leucovorin: increased toxicity without improved response in squamous cell head and neck cancer. Arch. Otolaryng. Head Neck Surg. 120 (1994), 89-95.
50. Rooney, M., J. Kish, J. Jacobs, J. Kinzie, A Weaver, J. Crissman, M. Al-Sarraf: Improved survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 55 (1985), 1123-1128
51. Salter, M. M., R. H. Wheeler, G. E. Peters, S Stephens, R. F Meredith, S. A. Spencer, R Y. Kim, B. Weppelmann: A phase I study of high-dose cisplatin, prolonged infusion 5-fluorouracil, and concomitant conventional fraction radiation therapy in patients with inoperable squamous cell carcinoma of the head and neck. Amer. J. clin. Oncol. 15 (1992), 461-463.
52. Sanchíz, F., A. Millá, J. Torner, F Nonet, N. Artola, L. Carreno, L. M. Moya, D. Riera, S. Ripol, L. Cirera: Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 19 (1990), 1347-1350.
53. Schratter-Sehn, A.-U., L. Handl-Zeller, H. Strassl, O. M. Braun, W. Dobrowsky: Inzidenz der Osteoradionekrose nach kombinierter Radiochemotherapie von Kopf-Hals-Tumoren. Strahlenther. Onkol. 167 (1991), 165-168.
54. Schuller, D. E., B. Metch, D. W. Stein, D. Mattox, J. D. McCracken: Pre-operative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope 98 (1988), 1205-1211.
55. SECOG. Cancer Research Campaign Clinical Trial Centre: A randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck. Europ. J. Surg. Oncol. 12 (1986), 289-295.
56. Tannock, I., B., G. Browman: Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. J. clin. Oncol. 4 (1986), 1121-1126.
57. Tannock, I., B. Cummings, V. Sorrenti and the ENT Group: Combination chemotherapy used prior to radiation therapy for locally advanced squamous cell carcinoma of the head and neck. Cancer Treatm. Rep. 66 (1982), 1421-1424.
58. Taylor IV, S. G., A. K. Murthy, J.-M. Vannetzel, P. Colin, M. Dray, D. D. Caldarelli, S. Shott E. Vokes, J. L. Showel, J. C. Hutchinson, T. R. Witt, K. L. Griem, W. F. Hartsell, M. S. Kies, B. Mittal, J.-L. Rebischung, D. J. Coupez. J.-L. Desphieux, S. Bobin, C. LePajolec: Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J. clin. Oncol. 12 (1994), 385-395.
59. Vermund, H., O. Kaalhus, F. Winther, J. Tausjo, E. Thorud, R. Harang: Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 11 (1985), 1877-1886.
60. Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients wich advanced laryngeal cancer. New Engl. J. Med. 324 (1991), 1685-1690.
61. Volkes, E. E., M. Kies, D. J. Haraf, R. Mick, W. J. Moran, M. Kozloff, B. Mittal, H. Pelzer, B. Wenig, W. Panje, R. R. Weichselbaum: Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease. J. clin. Oncol. 13 (1995), 876-883.
62. Volling, P., S. Staar, W. Achterrath, R.-P. Muller Carboplatin plus radiation therapy in head and neck cancer. Semin. Oncol. 18, Suppl. 2 (1991), 17-22.
63. Weinberg, M J , T. A. Lapointe, A. M. Rauth: Growth delay in a murine squamous cell tumor after local radiation and concurrent infusional 5-fluorouracil treatment. Int. J. Radiat. Oncol. Biol. Phys. 12 (1986), 1449-1452.
64. Weissberg, J. B., Y. H. Sun, R. J. Papac, C. Sasaki, D B. Fischer, R. Lawrence, S Rockwell, A. C. Sartorelli, J. J. Fischer Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J. Radiat. Oncol. Biol. Phys. 17 (1989), 3-9.
65. Wendt, T G., R. C. Hartenstein, T. P. U. Wustrow, J Lissner: Cis-platinum, 5-FU with folinic acid enhancement and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: a phase II study. J. clin. Oncol. 7 (1989), 471-476.
66. Wendt, T G., M. Panzer, T P. U. Wustrow, R. C. Hartenstein: Pattern of failure in long term survivors after simultaneous radio-chemotherapy for advanced head and neck cancer. Onkologie (1966), im Druck.
67. West, C. M. L.: Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Brit. J. Radiol. 68 (1995), 827-837.
68. Withers H., R., L. J. Peters, J. M.G. Taylor, J. B. Owen, W. H. Morrison, T. E Schultheiss, T. Keane, B. O'Sullivan, J. van Dyk, N. Gupta, C. C. Wang, C. U. Jones, K. D. Doppke, S. Myint, M Thompson, J T. Parsons, W. M. Mendenhall, S. Dische, E. G. A. Aird, J. M. Henk, M. A. M. Bidmead, V. Svoboda, Y. Chon, A. L. Hanlon, T. L. Peters, G. E. Hanks: Local control of the tonsil by radiation therapy: an analysis of pattern of fractionation in nine institutions. Int. J. Radiat. Oncol. Biol. 33 (1995), 549-562.
69. Withers, H. R., J. M. G. Taylor, B. Maciejewski: The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27 (1988), 131-146.
70. Wong, W., W., R. Mick, D. J. Haraf, R. R. Weichselbaum, E. E. Vokes: Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 29 (1994), 153-162.
71. Zamboglou, N., T. Schnabel, C. Kolotas, W. Achterrath, H. Strehl, S. Dahlhauser, H. G. Vogt, L. Lenaz, G. Schmitt: Carboplatin and radiotherapy in the treatment of head and neck cancer: Six years: experience. IL. Semin. Oncol. 21, Suppl. 12 (1994), 45-53.
72. Zatterstrom, U., K., E. Brun, R. Willen, E. Kjellen, J. Wennerberg: Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck 17 (1995), 312-318.
73. Zbaeren, P., W. Lehmann: Frequency and sites of distant metastases in head and neck squamous cell carcinoma. An analysis of 101 cases at autopsy. Arch. Otolaryng. Head Neck Surg. 113 (1987), 762-724.